Alpha Tau Medical Ltd.

NASDAQ:DRTS

2.56 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 000000000000000000000000
Cost of Revenue 00001.07400.51200.979000.2310.77600000000000
Gross Profit 0000-1.0740-0.5120-0.97900-0.231-0.77600000000000
Gross Profit Ratio 000000000000000000000000
Reseach & Development Expenses 7.5336.1736.8666.4487.496.6735.9556.3065.384.8275.4485.2353.2293.0322.9972.1892.6772.6771.5341.5341.6591.6591.6591.659
General & Administrative Expenses 2.0541.5881.5881.4432.0011.71.6931.9382.2082.2832.4433.3380.5880.50.3940.3790.4030.4030.3040.3040.3440.3440.3440.344
Selling & Marketing Expenses 0.6870.5290.60.5330.4520.5520.520.40.3970.2480.1210.2080.1260.1020.0870.1670.0730.0730.0720.0720.0990.0990.0990.099
SG&A 2.7412.1172.1881.9761.3792.2522.2132.3382.6052.5312.5643.5460.7140.6020.4810.5460.4750.4750.3750.3750.4430.4430.4430.443
Other Expenses 0006.448000000000000-4.694-4.694-4.694-4.694-4.104-4.104-4.104-4.104
Operating Expenses 10.2748.299.0548.4248.8698.9258.1688.6447.9857.3588.0128.7813.9433.6343.4782.7352.5572.5572.1122.112-2.003-2.003-2.003-2.003
Operating Income -10.274-8.29-9.054-8.424-9.943-8.925-8.168-8.644-7.985-7.358-8.012-8.781-3.943-3.634-3.478-2.735-2.713-2.713-1.909-1.909-2.003-2.003-2.003-2.003
Operating Income Ratio 000000000000000000000000
Total Other Income Expenses Net 0.81.3661.6880.4442.5863.974-0.4990.4784.5924.7446.019-16.9610.148-1.168-3.489-8.9650.2980.298-0.038-0.038-0.077-0.077-0.077-0.077
Income Before Tax -9.474-6.924-7.366-7.98-7.357-4.951-8.667-8.166-3.393-2.614-1.993-25.742-3.795-4.802-6.967-11.7-2.415-2.415-1.947-1.947-2.08-2.08-2.08-2.08
Income Before Tax Ratio 000000000000000000000000
Income Tax Expense 0.00200.0030.0010.008-0.0390.0260.0210.0030.0090.0060.002-0.014-0.0050.0150.0110.0070.0070.0730.0730.0370.0370.0370.037
Net Income -9.476-6.924-7.369-7.981-7.365-4.912-8.693-8.187-3.396-2.623-1.999-25.744-3.781-4.797-6.982-11.711-2.422-2.422-2.02-2.02-2.116-2.116-2.116-2.116
Net Income Ratio 000000000000000000000000
EPS -0.140-0.11-0.11-0.11-0.071-0.13-0.12-0.049-0.038-0.029-0.54-0.08-0.071-0.1-0.17-0.063-0.063-0.048-0.048-0.031-0.031-0.031-0.031
EPS Diluted -0.140-0.11-0.11-0.11-0.071-0.13-0.12-0.049-0.038-0.029-0.54-0.08-0.071-0.1-0.17-0.063-0.063-0.048-0.048-0.031-0.031-0.031-0.031
EBITDA -5.673-8.29-8.774-8.156-8.869-8.68-8.155-8.399-2.414-7.114-7.768-8.550.685-3.445-3.289-2.571-2.689-2.689-1.89-1.89-2.055-2.055-2.055-2.055
EBITDA Ratio 000000000000000000000000